Lumanity

Our unique & agile approach equip you to thrive in an ever-changing healthcare marketplace by accelerating & optimizing access to life-changing medicines

[Lumanity @lumanity]

How do you turn clinical expertise into quantifiable, HTA-compliant data?

Our "How-to" guide gives an overview of Structured Expert Elicitation, a rigorous methodology that can bridge evidence gaps in oncology, rare diseases, and ATMPs. https://t.co/nN5KEKePUe

#HEOR #SEE #HTA

[Lumanity @lumanity]

Want a deeper look at Lumanity's ISPOR 2026 poster?

Our new article expands on our research into cognitive debriefing, breaking down the proposed quantitative thresholds and minimum reporting standards for PRO content validation.https://t.co/5dpc17byI8

#CognitiveDebriefing #PRO

[Lumanity @lumanity]

The first JCA report is here. Our latest article looks beyond the headlines at what the tovorafenib report confirms and where ambiguity remains.

Find out more: https://t.co/vWDs87obOL

#JCA #HTA #MarketAccess

[Lumanity @lumanity]

Attending the European Pharmaceutical Market Research Association (EPHMRA) 2026? If so, don't miss "From Caution To Commitment: Tracking Pharma's Leap Into The Future Of Research" on Tuesday, June 23, 2026: https://t.co/ivP9zvGR8F

#MarketResearch #MarketInsights #EPHMRA2026

[Lumanity @lumanity]

We're just a few weeks away from the Insight Innovation Exchange (IIEX) Europe meeting! Will you be in Amsterdam for the meeting? If so, connect with our on-site experts by emailing [email protected]. https://t.co/kd5Tl5ar9Z

#IIEX2026 #MarketResearch #MarketInsights

[Lumanity @lumanity]

Listen to Michael Parisi, Chief Client Officer at Lumanity and Christine Verini, Chief Executive Officer at CancerCare discuss building aligned #Oncology innovation and value story across medical, access, #PatientAdvocacy, and commercial teams. https://t.co/dSjqH4hv6u
#ASCO26

[Lumanity @lumanity]

Drug pricing, patient evidence, AI, and the future of HEOR: our team was at #ISPORAnnual in Philadelphia and came back with a lot to say.

Find out more: https://t.co/fndO82WGWF

#LumanityPerspectives #HEOR #MarketAccess #PatientExperience

[Lumanity @lumanity]

Will we see you at the upcoming European #Hematology Association (EHA) 2026 Congress? If you're planning to be in Stockholm for the meeting, connect with our experts or email [email protected] to set up time to meet.

#EHA2026 #BloodDisorders #BorderlessHematology

[Lumanity @lumanity]

#PrideMonth honors the legacy, history, struggles, and achievements of those who have fought and continue to fight for the rights and recognition of #LGBTQ+ individuals.

Wishing our LGBTQ+ and Ally colleagues, alumni, clients, and followers a Happy Pride Month 2026!

[Lumanity @lumanity]

We've arrived at #ASCO26! Reach out to [email protected] or to one of our attendees directly to set up time in Chicago to discover how we can support your #oncology initiatives and drive better #PatientOutcomes. Learn more about our expertise: https://t.co/2qz3hIPyhT

[Lumanity @lumanity]

Rare disease teams often need robust evidence beyond what traditional trials can deliver—yet real-world data can be fragmented, hard to interpret, and risky to apply without the right approach. Check out our playbook guide: https://t.co/cgzxmaCUsM

#RWE #RWD #RareDisease

[Lumanity @lumanity]

HTA isn’t a checkpoint, it’s a strategy that starts early and evolves across the product lifecycle.

Our latest ‘How to’ guide explores what it takes to develop a successful HTA strategy. https://t.co/BJK6xTcQJA

#LumanityPerspectives #HTA #HEOR

[Lumanity @lumanity]

If you're planning to be in Chicago for #ASCO26, let's connect and discuss how we can support your #Oncology initiatives and drive better #PatientOutcomes. Reach out to [email protected] to set up time to meet. https://t.co/LkRp9it5AE

#CancerResearch #OncologyExpertise

[Lumanity @lumanity]

#ICYMI from AXS26: Access is the biggest barrier in specialty pharma, not innovation.
From CAR-T to biosimilars, the gap between breakthrough science and patient access is widening. Add AI, and the rules are changing fast. Read on: https://t.co/kX2DfcFK61
#MarketAccess

[Lumanity @lumanity]

Our recent webinar explores the growing importance of capturing patient experience during clinical trials.

In case you couldn't join us live, the recording is now available. Watch it here: https://t.co/ivAANEEUMk

#LumanityPerspectives #PatientCenteredEvidence

[Lumanity @lumanity]

In a recent study published in the Journal of #Hypertension, we used PHARMO data to investigate sex differences in the use of antihypertensive therapy & achievement of #BloodPressure targets among patients with hypertension in a real-world clinical setting https://t.co/hyLoA36rq0

[Lumanity @lumanity]

Alzheimer’s disease research has primarily focused on clinical cohorts, yet many patients are diagnosed and followed in primary care. Real-world data (RWD) can provide insight into disease trajectories. Read on: https://t.co/qIWaAYVMxI

#Dementia #Alzheimers #RWD #PrimaryCare

[Lumanity @lumanity]

The new EMA Real-World Data Quality Framework (RW-DQF) makes one thing clear: it is not enough to have real-world data - you need to show it’s fit-for-purpose for the specific regulatory question.

Read more: https://t.co/HhbkR9pCuh

#RWE #RWD #EMA #Regulatory #DataQuality

[Lumanity @lumanity]

Yesterday, we proudly participated in and sponsored BioNJ’s 16th annual @BioPartnering conference at the Liberty Science Center in Jersey City. A big thanks to our onsite team. Let's keep the conversation going! Email [email protected] to connect!
#BioNJ #Pharma #Biotech

[Lumanity @lumanity]

Meet with our Oncology Center of Excellence at the upcoming ASCO annual meeting! Learn more about our Oncology expertise: https://t.co/LkRp9it5AE and for a full list of the staff who will be at ASCO: https://t.co/PjPLCyPcrl

#ASCO26 #CancerResearch #OncologyExpertise